Home sweet home in Flint
anonymous Guest anonymous Mar 23, 2023 at 11:26: PM #82 anonymous Guest Well that explains a lot. Roller Disco drinking dirty water........
anonymous Guest anonymous Nov 27, 2023 at 03:43: AM #83 anonymous Guest MedinCell’s BEPO technology will be quickly bought by a big pharma. I don't know if it's TEVA but big offers would already be on the table
MedinCell’s BEPO technology will be quickly bought by a big pharma. I don't know if it's TEVA but big offers would already be on the table
anonymous Guest anonymous Nov 27, 2023 at 09:37: AM #84 anonymous Guest MedinCell’s BEPO technology will be quickly bought by a big pharma. I don't know if it's TEVA but big offers would already be on MedinCell’s table...
MedinCell’s BEPO technology will be quickly bought by a big pharma. I don't know if it's TEVA but big offers would already be on MedinCell’s table...
anonymous Guest anonymous Nov 30, 2023 at 02:35: AM #85 anonymous Guest anonymous said: MedinCell’s BEPO technology will be quickly bought by a big pharma. I don't know if it's TEVA but big offers would already be on MedinCell’s table... Click to expand... I hear layoffs by end of 2023, can anyone confirm ?
anonymous said: MedinCell’s BEPO technology will be quickly bought by a big pharma. I don't know if it's TEVA but big offers would already be on MedinCell’s table... Click to expand... I hear layoffs by end of 2023, can anyone confirm ?
anonymous Guest anonymous Nov 30, 2023 at 10:09: AM #86 anonymous Guest anonymous said: I hear layoffs by end of 2023, can anyone confirm ? Click to expand... It all depends on what they want to do with Ajovy. Not profitable in the Migraine market any longer and focus will be in Psych.
anonymous said: I hear layoffs by end of 2023, can anyone confirm ? Click to expand... It all depends on what they want to do with Ajovy. Not profitable in the Migraine market any longer and focus will be in Psych.
anonymous Guest anonymous Dec 01, 2023 at 01:09: PM #87 anonymous Guest anonymous said: It all depends on what they want to do with Ajovy. Not profitable in the Migraine market any longer and focus will be in Psych. Click to expand... Can’t we move Ajovy reps to products that are profitable like AUSTEDO ?
anonymous said: It all depends on what they want to do with Ajovy. Not profitable in the Migraine market any longer and focus will be in Psych. Click to expand... Can’t we move Ajovy reps to products that are profitable like AUSTEDO ?
anonymous Guest anonymous Dec 01, 2023 at 06:39: PM #88 anonymous Guest anonymous said: Can’t we move Ajovy reps to products that are profitable like AUSTEDO ? Click to expand... There are already too many people selling Austedo for the patient population we are going after, unless the NeuroHealth reps are taken off selling it and just focus on Uzedy.
anonymous said: Can’t we move Ajovy reps to products that are profitable like AUSTEDO ? Click to expand... There are already too many people selling Austedo for the patient population we are going after, unless the NeuroHealth reps are taken off selling it and just focus on Uzedy.
anonymous Guest anonymous Dec 01, 2023 at 10:40: PM #90 anonymous Guest anonymous said: Chris Fox is hot Click to expand... Teva is a sick and pathetic company , full of lies and deceit
anonymous said: Chris Fox is hot Click to expand... Teva is a sick and pathetic company , full of lies and deceit
anonymous Guest anonymous Jan 28, 2024 at 04:49: PM #92 anonymous Guest anonymous said: More layoffs coming Click to expand... After we just did a realignment? Doubt it.
anonymous Guest anonymous Feb 25, 2024 at 10:20: PM #93 anonymous Guest anonymous said: After we just did a realignment? Doubt it. Click to expand... Teva layoffs in Q1 2024?
anonymous said: After we just did a realignment? Doubt it. Click to expand... Teva layoffs in Q1 2024?
anonymous Guest anonymous Feb 26, 2024 at 10:37: AM #94 anonymous Guest Has TEVA got enough cash flow to pay final wages for layoffs ?
